Skip to Main Content

Author Details

Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
1998
60
35
PMIDPaper TitleJournal TitlePublished Year
37066184Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.bioRxiv2023
36059614PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells.Front Oncol2022
35937580NMR Spectroscopy-Based Metabolomics of Platelets to Analyze Brain Tumors.Reports (MDPI)2021
32882515Tunneling Nanotubes Mediate Adaptation of Glioblastoma Cells to Temozolomide and Ionizing Radiation Treatment.iScience2020
32059178Targeting glioma-initiating cells via the tyrosine metabolic pathway.J Neurosurg2020
31679017Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications.Neuro Oncol2020
32938908Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy.Nat Commun2020
30531922The molecular landscape of glioma in patients with Neurofibromatosis 1.Nat Med2019
32721125Current clinical management of patients with glioblastoma.Cancer Rep (Hoboken)2019
31463571The dystroglycan receptor maintains glioma stem cells in the vascular niche.Acta Neuropathol2019
31482267MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway.J Neurooncol2019
30759398Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.Cell Rep2019
29365204Ritanserin, a novel agent targeting the mesenchymal subtype of glioblastomas.Neuro Oncol2018
29644004IL-8 associates with a pro-angiogenic and mesenchymal subtype in glioblastoma.Oncotarget2018
28821207Targeting MIR155HG in glioma: a novel approach.Neuro Oncol2017
29166609GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.Cell Rep2017
29163847A relative increase in circulating platelets following chemoradiation predicts for poor survival of patients with glioblastoma.Oncotarget2017
29263302Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo.JCI Insight2017
28903422CDK4/6 inhibition is more active against the glioblastoma proneural subtype.Oncotarget2017
28740831The Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells.Front Oncol2017
26973881Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.JCI Insight2016
27569208FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.Cancer Res2016
26859459Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.Cancer Cell2016
25601206EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner.Stem Cell Reports2015
26558781Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.J Neurosci2015
26307681Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.Oncotarget2015
25546404Subclassification of newly diagnosed glioblastomas through an immunohistochemical approach.PLoS One2014
23993863Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.Cancer Cell2013
24135276EGFR and EGFRvIII in glioblastoma: partners in crime.Cancer Cell2013
23847350Not expecting the unexpected: diacylglycerol kinase alpha as a cancer target.Cancer Discov2013
22753228Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.Neuro Oncol2012
21653597Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.Neuro Oncol2011
22190458The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.Genes Dev2011
21561870Caspase-3 cleavage links delta-catenin to the novel nuclear protein ZIFCAT.J Biol Chem2011
20399149Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.Cancer Cell2010
20832751An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.Cancer Cell2010
20150367A multigene predictor of outcome in glioblastoma.Neuro Oncol2010
19421150Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters.Oncogene2009
18708058Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2.FEBS Lett2008
17235455PTEN down regulates AP-1 and targets c-fos in human glioma cells via PI3-kinase/Akt pathway.Mol Cell Biochem2007
17936560Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.Cancer Cell2007
17538175Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.J Clin Oncol2007
16005396Biomechanics and analysis of running gait.Phys Med Rehabil Clin N Am2005
15152193Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation.EMBO J2004
15326546Natural inhibitors of carcinogenesis.Planta Med2004
14612427Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.Mol Cell Biol2003
14636574Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.Mol Cell2003
11773503Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats.J Nutr2002
12074974Cancer chemopreventive activity of resveratrol.Ann N Y Acad Sci2002
11507064Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.Cancer Res2001
  • 1 - 50 of 60

Recommended Authors

Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Jin-Ku Lee
Seoul National University, College of Medicine
Career Start Year 2010
Number of shared co-authors 11
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 1
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 0
Harish N Vasudevan
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 4
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 10
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 6
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Kristiina Iljin
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
Jong Bae Park
Henan-Macquarie University Joint Centre for Biomedical Innovation, Henan University
Career Start Year 1997
Number of shared co-authors 11
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 15
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 24
Theresa M LaVallee
Parker Institute for Cancer Immunotherapy
Career Start Year 1996
Number of shared co-authors 0
Paul S Mischel
Stanford University
Career Start Year 1994
Number of shared co-authors 8
Xiao-Nan Li
Northwestern University
Career Start Year 1992
Number of shared co-authors 7
Frank B Furnari
University of California San Diego
Career Start Year 1992
Number of shared co-authors 11
Aykut Uren
Georgetown University Medical Center
Career Start Year 1991
Number of shared co-authors 0
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 11
Dirk Geerts
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 29
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 1
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 1
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 7
William A Weiss
University of California san francisco
Career Start Year 1985
Number of shared co-authors 9
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1984
Number of shared co-authors 23
Joshua B Rubin
Washington University in St. Louis
Career Start Year 1983
Number of shared co-authors 7
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 0
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 0

Collaborators

Erik P Sulman
NYU Grossman School of Medicine
Co-authored papers 16
Kenneth Aldape
National Cancer Institute
Co-authored papers 14
Ravesanker Ezhilarasan
Co-authored papers 7
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 7
Howard Colman
Huntsman Cancer Institute, University of Utah
Co-authored papers 7
Amy B Heimberger
Northwestern University Feinberg School of Medicine
Co-authored papers 6
Brian Vaillant
Dell Medical School, University of Texas at Austin
Co-authored papers 5
Ganesh Rao
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 4
Roel G W Verhaak
Yale School of Medicine
Co-authored papers 3
Qianghu Wang
Center for Global Health, School of Public Health, Nanjing Medical University
Co-authored papers 3
John F de Groot
Co-authored papers 3
Jun Wei
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers 3
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 3
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Co-authored papers 2
Tiffany Doucette
Baylor College of Medicine, The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers 2
Candelaria Gomez-Manzano
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 2
Rivka R Colen
Co-authored papers 2
Marta M Alonso
CIMA-Universidad de Navarra
Co-authored papers 2
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Co-authored papers 2
Yuhui Yang
Xuanwu Hospital, Capital Medical University
Co-authored papers 2
Jeongwu Lee
Lerner Research Institute, Cleveland Clinic
Co-authored papers 2
Michael D Prados
University of California san francisco
Co-authored papers 1
Dimpy Koul
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Co-authored papers 1
Marc Sanson
Co-authored papers 1
Dongquan Chen
University of Alabama at Birmingham
Co-authored papers 1
Michele Ceccarelli
Co-authored papers 1
Shivanand Pudakalakatti
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Release 1.2